Benzinga | Nov 10, 2020 08:19AM EST

Larimar Therapeutics Q3 EPS $(0.64) Up From $(1.42) YoY

Larimar Therapeutics (NASDAQ:LRMR) reported quarterly losses of $(0.64) per share. This is a 54.93 percent increase over losses of $(1.42) per share from the same period last year.